Related Experiment Video
Updated: May 16, 2025

Preparation of Exosomes for siRNA Delivery to Cancer Cells
Published on: December 5, 2018
Exosomes in melanoma: Future potential for clinical theranostics
Asmit Das1, Swarup Sonar1, Rajib Dhar2
1Department of Oncology and Maxillofacial Pathology, Neuron Institute of Applied Research, Amravati, Maharashtra, India.
Exosomes show promise for treating melanoma, a difficult skin cancer. These tiny vesicles can deliver drugs and boost immune responses against tumors, offering new therapeutic avenues.
Area of Science:
- Oncology
- Nanotechnology
- Immunology
Background:
- Melanoma is an aggressive skin cancer with limited treatment options.
- Exosomes, nanoscale vesicles, are explored for novel melanoma therapies.
- Exosomes offer biocompatibility and low immunogenicity for therapeutic applications.
Purpose of the Study:
- To review the therapeutic potential of exosomes in melanoma treatment.
- To explore exosome roles in modulating tumor behavior and immune response.
- To discuss exosomes as targeted drug delivery vehicles for melanoma.
Main Methods:
- Review of exosome engineering strategies for enhanced efficacy.
- Analysis of exosome loading with chemotherapeutics, siRNAs, and miRNAs.
- Examination of exosomes from diverse sources for anti-cancer effects.
Main Results:
- Exosomes can be engineered to deliver therapeutic payloads.
- Exosomes modulate tumor cell behavior and enhance anti-tumor immunity.
- Diverse exosome sources show potential for augmenting anti-cancer effects.
Conclusions:
- Exosome-based therapies hold significant promise for melanoma treatment.
- Engineering and diverse sourcing of exosomes enhance therapeutic potential.
- Standardized protocols and clinical evaluation are crucial for exosome therapy translation.
More Related Videos
09:30Using Nanoplasmon-Enhanced Scattering and Low-Magnification Microscope Imaging to Quantify Tumor-Derived Exosomes
Published on: May 24, 2019
08:49Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool
Published on: May 27, 2016
Related Concept Videos
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Clinical Applications of Epidermal Stem Cells